VB Spine Expands Globally with Australia and New Zealand Launch

VB Spine has launched in Australia and New Zealand, marking its first market entry outside the US. The company has acquired Stryker's spinal implants business in the region, expanding its presence in two fast-growing markets. VB Spine will continue to have exclusive access to Stryker's Mako Spine and Copilot automatic depth stop feature, creating a strong foundation for its growth. The company's vision is to put patients first and innovate boldly, with a family-run culture and strategic partnerships to improve outcomes.

VB Spine LLC has successfully launched its operations in Australia and New Zealand, marking its first market entry outside the United States. This strategic move comes following the acquisition of Stryker's spinal implants business in the region [2].

The acquisition, which was completed on July 1, 2025, signifies a significant milestone for VB Spine. The company will continue to have exclusive access to Stryker's Mako Spine and Copilot automatic depth stop feature, creating a strong foundation for its growth in the region [2]. VB Spine's vision is to put patients first and innovate boldly, with a family-run culture and strategic partnerships to improve outcomes [2].

The launch in Australia and New Zealand is part of VB Spine's broader strategy to expand its global footprint and enhance patient care. The company's comprehensive product portfolio and extensive distribution network will ensure that healthcare professionals have access to the latest tools and resources needed to provide high-standard care [2].

VB Spine's partnership with LifeHealthcare, the exclusive distributor of these products in Australia and New Zealand, will provide uninterrupted product availability and clinical support for surgeons and their patients. LifeHealthcare has been representing this portfolio since 2010, offering reliable access to spinal instrumentation and implants [2].

The expansion into Australia and New Zealand follows VB Spine's acquisition of Stryker's U.S. spinal implants business by Viscogliosi Brothers, LLC earlier this year. This acquisition has allowed VB Spine to leverage Stryker's technological advancements and innovative solutions to improve patient outcomes [2].

VB Spine's entry into the Australian and New Zealand markets aligns with its mission to drive growth and innovation in the neuro-musculoskeletal industry. The company's focus on operational excellence and patient-centric care is expected to have a positive impact on the healthcare system in these regions [2].

References:
[1] https://seekingalpha.com/news/4475920-stryker-non-gaap-eps-of-3_13-beats-by-0_06-revenue-of-6_02b-beats-by-90m
[2] https://www.businesswire.com/news/home/20250731453696/en/VB-Spine-Launches-in-Australia-and-New-Zealand